Journal of Medical Internet Research,
Journal Year:
2022,
Volume and Issue:
24(11), P. e39748 - e39748
Published: Aug. 25, 2022
Background
The
field
of
oncology
is
at
the
forefront
advances
in
artificial
intelligence
(AI)
health
care,
providing
an
opportunity
to
examine
early
integration
these
technologies
clinical
research
and
patient
care.
Hope
that
AI
will
revolutionize
care
delivery
improve
outcomes
has
been
accompanied
by
concerns
about
impact
on
equity.
Objective
We
aimed
conduct
a
scoping
review
literature
address
question,
“What
are
current
potential
impacts
equity
oncology?”
Methods
Following
PRISMA-ScR
(Preferred
Reporting
Items
for
Systematic
Reviews
Meta-Analyses
extension
Scoping
Reviews)
guidelines
reviews,
we
systematically
searched
MEDLINE
Embase
electronic
databases
from
January
2000
August
2021
records
engaging
with
key
concepts
AI,
equity,
oncology.
included
all
English-language
articles
engaged
3
concepts.
Articles
were
analyzed
qualitatively
themes
pertaining
influence
Results
Of
14,011
records,
133
(0.95%)
identified
our
included.
general
literature:
use
reduce
disparities
(58/133,
43.6%),
surrounding
bias
(16/133,
12.1%),
biological
social
determinants
(55/133,
41.4%).
A
total
3%
(4/133)
focused
many
themes.
Conclusions
Our
revealed
main
oncology,
which
relate
AI’s
ability
help
disparities,
its
mitigate
or
exacerbate
bias,
capability
elucidate
health.
Gaps
lack
discussion
ethical
challenges
application
low-
middle-income
countries,
problems
algorithms,
justification
over
traditional
statistical
methods
specific
questions
highlights
need
gaps
ensure
more
equitable
cancer
practice.
limitations
study
include
exploratory
nature,
focus
as
opposed
sectors,
analysis
solely
articles.
Journal of Medical Internet Research,
Journal Year:
2023,
Volume and Issue:
25, P. e43251 - e43251
Published: March 24, 2023
The
potential
of
artificial
intelligence
(AI)
to
reduce
health
care
disparities
and
inequities
is
recognized,
but
it
can
also
exacerbate
these
issues
if
not
implemented
in
an
equitable
manner.
This
perspective
identifies
biases
each
stage
the
AI
life
cycle,
including
data
collection,
annotation,
machine
learning
model
development,
evaluation,
deployment,
operationalization,
monitoring,
feedback
integration.
To
mitigate
biases,
we
suggest
involving
a
diverse
group
stakeholders,
using
human-centered
principles.
Human-centered
help
ensure
that
systems
are
designed
used
way
benefits
patients
society,
which
inequities.
By
recognizing
addressing
at
achieve
its
care.
International Journal of Bank Marketing,
Journal Year:
2023,
Volume and Issue:
42(1), P. 38 - 65
Published: July 4, 2023
Purpose
FinTech
offers
numerous
prospects
for
significant
enhancements
and
fundamental
changes
in
financial
services.
However,
along
with
the
myriad
of
benefits,
it
also
has
potential
to
induce
risks
individuals,
organisations
society.
This
study
focuses
on
understanding
developers’
perspective
dark
side
FinTech.
Design/methodology/approach
conducted
semi-structured
interviews
23
Nigerian
developers
using
an
exploratory,
inductive
methodology
The
data
were
transcribed
then
thematically
analysed
NVivo.
Findings
Three
themes
–
customer
vulnerability,
technical
inability
regulatory
irresponsibility
arose
from
thematic
analysis.
poor
existing
technological
infrastructure,
management
challenges,
limited
access
smartphone
adoption
pose
challenges
a
speedy
integration
country,
making
customers
vulnerable.
lack
privacy
control
leads
ethical
issues.
skilled
brain
drain
good
present
additional
obstacles
development
Nigeria.
Research
limitations/implications
operation
developing
country
differs
that
developed
countries
better
infrastructure
institutional
acceptance.
recognises
basic
banking
operations
through
are
still
not
well
adopted,
necessitating
need
be
more
open-minded
about
global
practicalities
Practical
implications
managers,
banks
policymakers
can
ethically
collect
consumer
help
influence
credit
decisions,
product
recommendations
mobile
app
transaction
history.
There
should
strict
penalties
selling
customers’
data,
sending
unsolicited
messages
or
gaining
unnecessary
customer’s
contact
list.
offer
educate
consumers
their
skills.
Originality/value
Whereas
other
studies
have
focused
positive
aspects
understand
client
perceptions,
this
new
insights
into
by
analysing
viewpoints
developers.
Furthermore,
is
based
Nigeria,
emerging
economy
adopting
FinTech,
adding
dimension
body
knowledge.
PLOS Digital Health,
Journal Year:
2023,
Volume and Issue:
2(5), P. e0000237 - e0000237
Published: May 19, 2023
Artificial
intelligence
(AI)
has
the
potential
to
improve
diagnostic
accuracy.
Yet
people
are
often
reluctant
trust
automated
systems,
and
some
patient
populations
may
be
particularly
distrusting.
We
sought
determine
how
diverse
feel
about
use
of
AI
tools,
whether
framing
informing
choice
affects
uptake.
To
construct
pretest
our
materials,
we
conducted
structured
interviews
with
a
set
actual
patients.
then
pre-registered
(osf.io/9y26x),
randomized,
blinded
survey
experiment
in
factorial
design.
A
firm
provided
n
=
2675
responses,
oversampling
minoritized
populations.
Clinical
vignettes
were
randomly
manipulated
eight
variables
two
levels
each:
disease
severity
(leukemia
versus
sleep
apnea),
is
proven
more
accurate
than
human
specialists,
clinic
personalized
through
listening
and/or
tailoring,
avoids
racial
financial
biases,
Primary
Care
Physician
(PCP)
promises
explain
incorporate
advice,
PCP
nudges
towards
as
established,
recommended,
easy
choice.
Our
main
outcome
measure
was
selection
or
physician
specialist
(binary,
“AI
uptake”).
found
that
weighting
representative
U.S.
population,
respondents
almost
evenly
split
(52.9%
chose
doctor
47.1%
clinic).
In
unweighted
experimental
contrasts
who
met
criteria
for
engagement,
PCP’s
explanation
superior
accuracy
increased
uptake
(OR
1.48,
CI
1.24–1.77,
p
<
.001),
did
nudge
established
1.25,
CI:
1.05–1.50,
.013),
reassurance
had
trained
counselors
listen
patient’s
unique
perspectives
1.27,
1.07–1.52,
.008).
Disease
apnea)
other
manipulations
not
affect
significantly.
Compared
White
respondents,
Black
selected
less
.73,
.55-.96,
.023)
Native
Americans
it
(OR:
1.37,
1.01–1.87,
.041).
Older
likely
choose
.99,
.987-.999,
.03),
those
identified
politically
conservative
.65,
.52-.81,
.001)
viewed
religion
important
.64,
.52-.77,
.001).
For
each
unit
increase
education,
odds
1.10
greater
selecting
an
provider
1.10,
1.03–1.18,
.004).
While
many
patients
appear
resistant
AI,
information,
experience
help
acceptance.
ensure
benefits
secured
clinical
practice,
future
research
on
best
methods
incorporation
decision
making
required.
Cureus,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Jan. 10, 2024
The
simulation
of
human
intelligence
in
robots
that
are
designed
to
think
and
learn
like
humans
is
known
as
artificial
(AI).
AI
creating
a
world
has
never
been
seen
before.
By
applying
do
jobs
would
otherwise
take
long
time,
have
the
chance
improve
our
planet.
great
potential
genetic
engineering
gene
therapy
research.
powerful
tool
for
new
hypotheses
helping
with
experimental
techniques.
From
previous
data
model,
it
can
help
detection
heredity
gene-related
disorders.
developments
offer
an
excellent
possibility
rational
drug
discovery
design,
eventually
impacting
humanity.
Drug
development
depend
greatly
on
machine
learning
(ML)
technology.
Genetics
not
exception
this
trend,
ML
expected
impact
nearly
every
aspect
experience.
significantly
aided
treatment
various
biomedical
conditions,
including
In
both
basic
applied
research,
deep
-
highly
versatile
branch
enables
autonomous
feature
extraction
increasingly
exploited.
review,
we
cover
broad
spectrum
current
uses
genetics.
enormous
field
genetics,
but
its
advancement
area
may
be
hampered
future
by
lack
knowledge
about
accompanying
difficulties
could
mask
any
possible
benefits
patients.
This
paper
examines
AI's
significance
advancing
precision
disease
treatment,
provides
peek
at
use
clinical
care,
number
existing
clinician
primer
critical
aspects
these
technologies,
makes
predictions
applications
illnesses.
Journal of Biomedical Science,
Journal Year:
2025,
Volume and Issue:
32(1)
Published: Feb. 7, 2025
Abstract
Artificial
intelligence
(AI)
has
emerged
as
a
transformative
force
in
precision
medicine,
revolutionizing
the
integration
and
analysis
of
health
records,
genetics,
immunology
data.
This
comprehensive
review
explores
clinical
applications
AI-driven
analytics
unlocking
personalized
insights
for
patients
with
autoimmune
rheumatic
diseases.
Through
synergistic
approach
integrating
AI
across
diverse
data
sets,
clinicians
gain
holistic
view
patient
potential
risks.
Machine
learning
models
excel
at
identifying
high-risk
patients,
predicting
disease
activity,
optimizing
therapeutic
strategies
based
on
clinical,
genomic,
immunological
profiles.
Deep
techniques
have
significantly
advanced
variant
calling,
pathogenicity
prediction,
splicing
analysis,
MHC-peptide
binding
predictions
genetics.
AI-enabled
including
dimensionality
reduction,
cell
population
identification,
sample
classification,
provides
unprecedented
into
complex
immune
responses.
The
highlights
real-world
examples
medicine
platforms
decision
support
tools
rheumatology.
Evaluation
outcomes
demonstrates
benefits
impact
these
approaches
care.
However,
challenges
such
quality,
privacy,
clinician
trust
must
be
navigated
successful
implementation.
future
lies
continued
research,
development,
to
unlock
care
drive
innovation
This
comprehensive
review
explores
the
implications
of
artificial
intelligence
(AI)
in
addressing
cochlear
implant
(CI)
issues
and
revolutionizing
landscape
auditory
prosthetics.
It
begins
with
an
overview
ear
anatomy
hearing
loss,
then
a
CI
technology
its
current
challenges.
The
emphasizes
how
advanced
AI
algorithms
data-driven
approaches
enhance
adaptability
functionality,
enabling
personalized
rehabilitation
strategies
improving
speech
enhancement.
highlights
diverse
applications
rehabilitation,
including
real-time
adaptive
control
mechanisms
cognitive
assistants
that
help
users
manage
their
health.
By
outlining
innovative
pathways
future
directions
for
AI-enhanced
CIs,
paper
sets
stage
transformative
shift
prosthetics,
aiming
to
improve
quality
life
individuals
loss.
OMICS A Journal of Integrative Biology,
Journal Year:
2019,
Volume and Issue:
24(5), P. 247 - 263
Published: July 17, 2019
Historically,
the
term
"artificial
intelligence"
dates
to
1956
when
it
was
first
used
in
a
conference
at
Dartmouth
College
US.
Since
then,
development
of
artificial
intelligence
has
part
been
shaped
by
field
neuroscience.
By
understanding
human
brain,
scientists
have
attempted
build
new
intelligent
machines
capable
performing
complex
tasks
akin
humans.
Indeed,
future
research
into
will
continue
benefit
from
study
brain.
While
algorithms
fast
paced,
actual
use
most
(AI)
biomedical
engineering
and
clinical
practice
is
still
markedly
below
its
conceivably
broader
potentials.
This
partly
because
for
any
algorithm
be
incorporated
existing
workflows
stand
test
scientific
validation,
personal
utility,
application
context,
equitable
as
well.
In
this
there
much
gained
combining
AI
(HI).
Harnessing
Big
Data,
computing
power
storage
capacities,
addressing
societal
issues
emergent
applications,
demand
deploying
HI
tandem
with
AI.
Very
few
countries,
even
economically
developed
states,
lack
adequate
critical
governance
frames
best
understand
steer
innovation
trajectories
health
care.
Drug
discovery
translational
pharmaceutical
gain
technology
provided
they
are
also
informed
HI.
expert
review,
we
analyze
ways
which
applications
likely
traverse
continuum
life
birth
death,
encompassing
not
only
humans
but
all
animal,
plant,
other
living
organisms
that
increasingly
touched
Examples
include
digital
health,
diagnosis
diseases
newborns,
remote
monitoring
smart
devices,
real-time
Data
analytics
prompt
heart
attacks,
facial
analysis
software
consequences
on
civil
liberties.
underscore
need
integration
HI,
note
does
replace
medical
specialists
or
rather,
such
Altogether,
offer
synergy
responsible
veritable
prospects
improving
care
prevention
therapeutics
while
unintended
automation
should
borne
mind
cultures,
work
force,
society
large.
Trends in Genetics,
Journal Year:
2019,
Volume and Issue:
35(11), P. 852 - 867
Published: Oct. 14, 2019
Next-generation
sequencing
(NGS)
technologies
have
changed
the
landscape
of
genetic
testing
in
rare
diseases.
However,
rapid
evolution
NGS
has
outpaced
its
clinical
adoption.
Here,
we
re-evaluate
critical
steps
application
NGS-based
from
an
informatics
perspective.
We
suggest
a
'fit-for-purpose'
triage
current
technologies.
also
point
out
potential
shortcomings
management
variants
and
offer
ideas
for
improvement.
specifically
emphasize
importance
ensuring
accuracy
reproducibility
context
disease
diagnosis.
highlight
role
artificial
intelligence
(AI)
enhancing
understanding
prioritization
variance
setting
propose
deep
learning
frameworks
further
investigation.